Premium Phosphosite-Specific 7TM Antibodies
Your Resource for GPCR Research
Select Your Country of Delivery below

Corticotropin-Releasing Factor Receptor 1 Antibodies

Close filters
No results were found for the filter!
Rabbit Monoclonal
NEW
Validation of the Corticotropin-Releasing Factor Receptor 1 in transfected HEK293 cells
CRF1 [UMB19]...
The non-phospho-CRF1 antibody is directed against the distal end of the carboxyl-terminal tail of human CRF1. It can be used to detect total CRF1 receptors in Western blots independent of phosphorylation. The CRF1 antibody can also be...
$ 495.00 *
NEW
Validation of the Corticotropin-Releasing Factor Receptor 1 in transfected HEK293 cells
CRF1 (non-phospho-Corticotropin-Releasing...
The non-phospho-CRF1 receptor antibody is directed against the distal part of the carboxyl-terminal tail of human CRF1. It can be used to detect total CRF1 receptors in Western blots independent of phosphorylation. The non-phospho-CRF1...
$ 375.00 *
NEW
Immunohistochemical identification of Corticotropin-Releasing Factor Receptor 1 in anterior pituitary
CRF1 (IHC-grade), Corticotropin-Releasing...
The CRF1 receptor antibody is directed against the distal part of the carboxyl-terminal tail of human CRF1. It can be used to detect total CRF1 receptors in Western blots independent of phosphorylation. The CRF1 antibody can also be used...
$ 375.00 *
NEW
Agonist-induced Threonine428/Serine429 phosphorylation of CRF1 Receptor
pT428/pS429-CRF1...
Threonine428/Serine429 (T428/S429) is a major phosphorylation site of the CRF1 receptor. The pT428/pS429-CRF1 antibody detects phosphorylation in response to high-efficacy agonists. T428/S429 phosphorylation is a key regulator of CRF1...
$ 375.00 *
NEW
Agonist-induced Threonine431 phosphorylation of CRF1 Receptor
pT431-CRF1 (phospho-Corticotropin-Releasing...
Threonine431 (T431) is a major phosphorylation site of the CRF1 receptor. The pT431-CRF1 antibody detects phosphorylation in response to high-efficacy agonists. T431 phosphorylation is a key regulator of CRF1 desensitization, β-arrestin...
$ 375.00 *
NEW
Agonist-induced Serine434/Serine437 phosphorylation of CRF1 Receptor
pS434/pS437-CRF1...
Serine434/Serine441 (S437/S441) is a major phosphorylation site of the CRF1 receptor. The pS434/pS437-CRF1 antibody detects phosphorylation in response to high-efficacy agonists. S434/S437 phosphorylation is a key regulator of CRF1...
$ 375.00 *

Corticotropin-releasing factor receptor 1 (CRF₁), encoded by CRHR1, is a class B1 G protein-coupled receptor activated by corticotropin-releasing factor (CRF, also known as CRH) and urocortin 1. It couples predominantly to Gs, stimulating adenylyl cyclase and increasing intracellular cAMP. CRF₁ is expressed in anterior pituitary corticotrophs and in brain regions involved in stress and emotional processing, including the cortex and amygdala. In the pituitary, CRF₁ activation stimulates adrenocorticotropic hormone (ACTH) release, which in turn drives adrenal cortisol secretion. In the brain, CRF₁ signaling contributes to behavioral and autonomic responses to stress. Sustained agonist exposure can induce receptor desensitization, β-arrestin recruitment, and clathrin-mediated internalization. The selective oral CRF₁ antagonist crinecerfont reduces ACTH-driven adrenal androgen production. In the United States, crinecerfont is approved as an adjunct to glucocorticoid replacement to control androgen levels in patients aged four years and older with classic congenital adrenal hyperplasia. CRF1 receptor desensitization, β-arrestin recruitment and internalization are regulated by phosphorylation of carboxyl-terminal threonine428/serine429 (pT428/pS429-CRF1), threonine431 (pT431-CRF1) and serine434/serine437 (pS434/pS437-CRF1). This nomenclature refers to the human CRF1 receptor. This phosphorylation motif is highly conserved across species but corresponds to pT399/pS400-CRF1, pT402/pS405-CRF1 and pS408/pS412-CRF1 in mice and rats. Interestingly, a very similar phosphorylation motif is present in the human CRF2 receptor which corresponds to pT395/pS396-CRF2, pT398/pS401-CRF2 and pS404/pT408-CRF2. For more information on CRF1 pharmacology please refer to the IUPHAR database. For further reading refer to:

Hauger RL, Grigoriadis DE, Dallman MF, Plotsky PM, Vale WW, Dautzenberg FM. International Union of Pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands. Pharmacol Rev. 2003 Mar;55(1):21-6. doi: 10.1124/pr.55.1.3. PMID: 12615952.

Corticotropin-releasing factor receptor 1 (CRF₁), encoded by CRHR1 , is a class B1 G protein-coupled receptor activated by corticotropin-releasing factor (CRF, also known as CRH) and... read more »
Close window
Corticotropin-Releasing Factor Receptor 1 Antibodies

Corticotropin-releasing factor receptor 1 (CRF₁), encoded by CRHR1, is a class B1 G protein-coupled receptor activated by corticotropin-releasing factor (CRF, also known as CRH) and urocortin 1. It couples predominantly to Gs, stimulating adenylyl cyclase and increasing intracellular cAMP. CRF₁ is expressed in anterior pituitary corticotrophs and in brain regions involved in stress and emotional processing, including the cortex and amygdala. In the pituitary, CRF₁ activation stimulates adrenocorticotropic hormone (ACTH) release, which in turn drives adrenal cortisol secretion. In the brain, CRF₁ signaling contributes to behavioral and autonomic responses to stress. Sustained agonist exposure can induce receptor desensitization, β-arrestin recruitment, and clathrin-mediated internalization. The selective oral CRF₁ antagonist crinecerfont reduces ACTH-driven adrenal androgen production. In the United States, crinecerfont is approved as an adjunct to glucocorticoid replacement to control androgen levels in patients aged four years and older with classic congenital adrenal hyperplasia. CRF1 receptor desensitization, β-arrestin recruitment and internalization are regulated by phosphorylation of carboxyl-terminal threonine428/serine429 (pT428/pS429-CRF1), threonine431 (pT431-CRF1) and serine434/serine437 (pS434/pS437-CRF1). This nomenclature refers to the human CRF1 receptor. This phosphorylation motif is highly conserved across species but corresponds to pT399/pS400-CRF1, pT402/pS405-CRF1 and pS408/pS412-CRF1 in mice and rats. Interestingly, a very similar phosphorylation motif is present in the human CRF2 receptor which corresponds to pT395/pS396-CRF2, pT398/pS401-CRF2 and pS404/pT408-CRF2. For more information on CRF1 pharmacology please refer to the IUPHAR database. For further reading refer to:

Hauger RL, Grigoriadis DE, Dallman MF, Plotsky PM, Vale WW, Dautzenberg FM. International Union of Pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands. Pharmacol Rev. 2003 Mar;55(1):21-6. doi: 10.1124/pr.55.1.3. PMID: 12615952.

Recently viewed